SEC Tracker
Get the app

SAB Biotherapeutics SABS

SAB Biotherapeutics: signs a material agreement and reports an executive or board change

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when SAB Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.